Steven Lazer, global healthcare and life sciences chief technology officer at Dell Technologies, sat down with MobiHealthNews during the 2023 HIMSS Global Health Conference & Exhibition to discuss how he takes intellectual property from Dell, as well as from other organizations, and brings it together with technology to create solutions for the healthcare and life sciences team....
Pfizer completes ResApp purchase for over $115 million
Biopharmaceutical giant Pfizer has finalised its acquisition of ASX-listed digital health startup ResApp for A$179 million ($116 million), according to the University of Queensland.
Brisbane-based ResApp has developed a mobile app that analyses cough sounds and diagnoses respiratory diseases, including asthma, pneumonia, bronchiolitis, croup...
